Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 44, Issue 1, 2010, Pages 66-73

  Xia, Shijin ^a,d   Tai, Xiantao ^b,c   Wang, Yaoli ^d   An, Xiaojing ^a   Qian, Guisheng ^d   Dong, Jingcheng ^b   Wang, Xun ^a   Sha, Baokang ^a   Wang, Diane ^g   Murthi, Padma ^e,f   Kalionis, Bill ^e,f   Wang, Xiangdong ^a   Bai, Chunxue ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c YUNNAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

^e ROYAL WOMEN'S HOSPITAL   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g NONE

Author keywords

Extracellular signal regulated kinase 1; Gax; Hypoxia; Pulmonary hypertension; Smooth muscle

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ADENOVIRUS VECTOR; GROWTH ARREST SPECIFIC HOMEOBOX PROTEIN; HOMEODOMAIN PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY MUSCLE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE RESISTANCE; DRUG TARGETING; GENE FUNCTION; GENE REPRESSION; GENETIC TRANSFECTION; HEART RIGHT VENTRICLE HYPERTROPHY; HYPOXIA; LUNG BLOOD VESSEL; MALE; NONHUMAN; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; SMOOTH MUSCLE FIBER;

ADENOVIRIDAE; ANIMALS; ANOXIA; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL HYPOXIA; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENETIC VECTORS; HOMEODOMAIN PROTEINS; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-BCL-2; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; RNA, MESSENGER; TRANSFECTION;

RATTUS;

EID: 78650665473     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0442OC     Document Type: Article

References (46)

1. Meyrick B, Reid L. The effect of chronic hypoxia on pulmonary arteries in young rats. Exp Lung Res 1981;2:257-271.
2. Stenmark R, Fagan K, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 2006;99:675-691.
3. Jeffery TK, Morrell NW. Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Prog Cardiovasc Dis 2002;45:173-201.
4. Jeffery TK, Wanstall JC. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 2001;92:1-20.
5. Esteve JM, Launay JM, Kellermann O, Maroteaux L. Functions of serotonin in hypoxic pulmonary vascular remodeling. Cell Biochem Biophys 2007;47:33-44.
6. Barberà JA, Peinado VI, Santos S. Pulmonary hypertension in COPD: old and new concepts. Monaldi Arch Chest Dis 2000;55:445-449.
7. Voelkel NF, Tuder RM. Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest 2000;106:733-738.
8. Schannwell CM, Steiner S, Strauer BE. Diagnostics in pulmonary hypertension. J Physiol Pharmacol 2007;58:591-602.
9. Wagenvoort CA. Vasoconstriction and medial hypertrophy in pulmonary hypertension. Circulation 1960;22:535-546.
10. Gorski DH, LePage DF, Patel CV, Copeland NG, Jenkins NA, Walsh K. Molecular cloning of a diverged homeobox gene that is rapidly downregulated during the G0/G1 transition in vascular smooth muscle cells. Mol Cell Biol 1993;13:3722-3733.
11. Weir L, Chen D, Pastore C, Isner JM, Walsh K. Expression of Gax, a growth arrest homeobox gene, is rapidly down-regulated in the rat carotid artery during the proliferative response to balloon injury. J Biol Chem 1995;270:5457-5461.
12. Smith RC, Branellec D, Gorski DH, Guo K, Perlman H, Dedieu JF, Pastore C, Mahfoudi A, Denèfle P, Isner JM, et al. p21CIP1-mediated inhibition of cell proliferation by overexpression of the Gax homeodomain gene. Genes Dev 1997;11:1674-1689.
13. Perlman H, Luo Z, Krasinski K, Le Roux A, Mahfoudi A, Smith RC, Branellec D, Walsh K. Adenovirus-mediated delivery of the Gax transcription factor to rat carotid arteries inhibits smooth muscle proliferation and induces apoptosis. Gene Ther 1999;6:758-763.
14. Perlman H, Sata M, Le Roux A, Sedlak TW, Branellec D, Walsh K. Baxmediated cell death by the Gax homeoprotein requires mitogen activation but is independent of cell cycle activity. EMBO J 1998; 17:3576-3586.
15. Maillard L, Van Belle E, Tio FO, Rivard A, Kearney M, Branellec D, Steg PG, Isner JM, Walsh K. Effect of percutaneous adenovirusmediated Gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries. Gene Ther 2000;7: 1353-1361.
16. Xia SJ, Dong JC, Bai L, Hu MD, Qian GS, Tai XT, Xie JY. The effects of Ad-Gax transfection on apoptosis and related gene expression in pulmonary arterial smooth muscle cells in hypoxic rat model. Zhonghua Nei Ke Za Zhi 2007;46:755-759.
17. Xia SJ, Dong JC, Tai XT, Wang YL, Qian GS. The effect of overexpression of Gax gene on proliferation of rat pulmonary arterial smooth muscle cells exposed to hypoxia. Zhonghua Nei Ke Za Zhi 2008;47:505-506.
18. Janssens SP, Bloch KD, Nong Z, Gerard RD, Zoldhehyi P, Collen D. Adenoviral mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. J Clin Invest 1996;98:317-324.
19. Christou H, Yoshida A, Arthur V, Morita T, Kourembanas S. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol 1998;162:768-776.
20. Christou H, Morita T, Hsieh CM, Koike H, Arkonac B, Perrella MA, Kourembanas S. Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 2000;86:1224-1229.
21. Van Suylen RJ, Smits JFM, Daemen MJAP. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension. Am J Respir Crit Care Med 1998;157:1423-1428.
22. Rosete DP, Manjarrez1 ME, Barrón BL. Adenoviruses C in nonhospitalized Mexican children older than five years of age with acute respiratory infection. Mem Inst Oswaldo Cruz 2008;103: 195-200.
23. Arjona AA, Hsu CA, Wrenn DS, Hill NS. Effects of natriuretic peptides on vascular smooth-muscle cells derived from different vascular beds. Gen Pharmacol 1997;28:387-392.
24. Liu P, Zhang C, Feng JB, Zhao YX, Wang XP, Yang JM, Zhang MX, Wang XL, Zhang Y. Cross-talk among Smad, MAPK, and integrin signaling pathways enhances adventitial fibroblast functions activated by transforming growth factor-β1 and inhibited by Gax. Arterioscler Thromb Vasc Biol 2008;28:725-731.
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
26. Morrell NW, Upton PD, Kotecha S, Huntley A, Yacoub MH, Polak JM, Wharton J. Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth msucle via AT1 receptors. Am J Physiol 1999;277:L440-L448.
27. Kayyali US, Pennella CM, Trujillo C, Villa O, Gaestel M, Hassoun PM. Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2. J Biol Chem 2002;277:42596-42602.
28. Das M, Dempsey EC, Reeves JT, Stenmark KR. Selective expansion of fibroblast subpopulations from pulmonary artery adventitia in response to hypoxia. Am J Physiol 2002;282:L976-L986.
29. Welsh DJ, Peacock AJ, MacLean M, Maclean M, Harnett M. Chronic hypoxia induces constitutive p38 mitogen activated protein kinase activity that correlates with enhanced cellular proliferation in fibroblasts from rat pulmonary but not systemic arteries. Am J Respir Crit Care Med 2001;164:282-289.
30. Scott PH, Paul A, Belham CM, Peacock AJ, Wadsworth RM, Gould GW, Welsh D, Plevin R. Hypoxic stimulation of the stress-activated protein kinases in pulmonary artery fibroblasts. Am J Respir Crit Care Med 1998;158:958-962.
31. Kito H, Chen EL, Wang XJ, Ikeda M, Azuma N, Nakajima N, Gahtan V, Sumpio BE. Role of mitogen-activated protein kinases in pulmonary endothelial cells exposed to cyclic strain. J Appl Physiol 2000;89: 2391-2400.
32. Ishihata A, Tasaki K, Katano Y. Involvement of p44/42 mitogen-activated protein kinases in regulating angiotensin II- and endothelin-1- induced contraction of rat thoracic aorta. Eur J Pharmacol 2002;445: 247-256.
33. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Bio1 Chem 1995;270:14843-14846.
34. Liu W, Liu Y, Lowe WL. The role of phosphatidylinositol 3-kinase and the mitogen-activated protein kinases in insulin-like growth factor-1-mediated effects in vascular endothelial cells. Endocrinology 2001; 142:1710-1719.
35. Finlay GA, Thannickal VJ, Fanburg BL, Paulson KE. Transforming growth factor-β1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. J Biol Chem 2000;275:27650-27656.
36. Jin N, Hatton N, Swartz DR, Xia X, Harrington MA, Larsen SH, Rhoades RA. Hypoxia activates jun-N-terminal kinase, extracellular signal-regulated protein kinase, and p38 kinase in pulmonary arteries. Am J Respir Cell Mol Biol 2000;23:593-601.
37. Conrad PW, Freeman TL, Beitner-Johnson D, Millhorn DE. EPAS 1 trans-activation during hypoxia requires p42/p44 MAPK. J Bio1 Chem 1999;274:33709-33713.
38. Minet E, Amould T, Michel G, Roland I, Mottet D, Raes M, Remacle J, Michiels C. ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett 2000;468:53-58.
39. Preston IR, Hill NS, Warburton RR, Fanburg BL. Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol 2006;290:L367-L374.
40. Saito T, Itoh H, Yamashita J, Doi K, Chun TH, Tanaka T, Inoue M, Masatsugu K, Fukunaga Y, Sawada N, et al. Angiotensin II suppresses growth arrest specific homeobox (Gax) expression via redox-sensitive mitogen-activated protein kinase (MAPK). Regul Pept 2005;127:159-167.
41. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407: 770-776.
42. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281: 1309-1312.
43. Cory S, Huang DCS, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003;22:8590-8607.
44. McCubrey JA, Steelman LS, Blalock WL, Lee JT, Moye PW, Chang F, Pearce M, Shelton JG, White MK, Franklin RA, et al. Synergistic effects of Pi3k/Akt on abrogation of cytokine-dependency induced by oncogenic Raf. Adv Enzyme Regul 2001;41:289-323.
45. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-1326.
46. Tripathy SK, Black HB, Goldwasser E, Leiden JM. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vector. Nat Med 1996;2:545-550.